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Abstract We have clarified for the first time how cyanidin 3-O-
L-D-glucoside (C3G), which is a potent antioxidant anthocyanin,
is absorbed and metabolized in vivo. Rats were orally
administered C3G (0.9 mmol/kg body weight), and C3G rapidly
appeared in the plasma. However, the aglycon of C3G (cyanidin;
Cy) was not detected, although it was present in the jejunum.
Protocatechuic acid (PC), which may be produced by degrada-
tion of Cy, was present in the plasma and the concentration was
8-fold higher than that of C3G. These results suggest that plasma
PC and C3G may contribute to the antioxidant activity of the
plasma. In the liver and kidney, C3G was metabolized to
methylated C3G (methyl-C3G), suggesting that C3G and/or
methyl-C3G act as antioxidants in the tissues.
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1. Introduction
Anthocyanins are the largest group of water-soluble pig-
ments in the plant kingdom. They are widely distributed in
the human diet through crops, beans, fruits, vegetables and
red wines [1], suggesting that we ingest considerable amounts
of anthocyanins from plant-based daily diets. The average
intake of £avonoids by humans was estimated to range
from 25 mg/day to 1 g/day [2,3], however, the intake of the
anthocyanins has not been estimated.
There is now an increasing interest in the in vivo protective
function of natural antioxidants contained in dietary plants
against oxidative damage caused by free radical species [4,5].
The antioxidant activity of phenolic phytochemicals has been
widely investigated [6,7]. Anthocyanins, which are included in
the phenolic phytochemicals, are stable under acidic condi-
tions but not stable and rapidly broken down under neutral
condition [8]. From this background, anthocyanins have not
been recognized as a physiological antioxidant [8]. However,
we demonstrated in an in vitro study that anthocyanins have
antioxidative activity under physiological conditions [9,10].
Among the anthocyanins tested, cyanidin 3-O-L-D-glucoside
(C3G) (Fig. 1) had a signi¢cant antioxidative activity [11].
We recently reported in an in vivo study using rats that
C3G feeding lowered the serum thiobarbituric acid-reactive
substance (TBARS) concentration, and increased the oxida-
tion resistance of the serum against lipid peroxidation [12].
Recent reports showed that phenolic compounds contained
in red wine may play an important role as inhibitors of low-
density lipoprotein (LDL) oxidation [13]. Red wine contains a
large amount of anthocyanins, such as C3G [14], indicating
that these anthocyanin pigments may contribute to the inhib-
itory e¡ect of the oxidation of LDL. However, it has not been
clari¢ed how anthocyanins are metabolized in vivo.
We also reported that C3G was able to react with peroxyl
radicals, and then convert itself in vitro to the oxidation prod-
ucts 4,6-dihydroxy-2-O-L-D-glucosyl-3-oxo-2,3-dihydrobenzo-
furan and protocatechuic acid (PC) (Fig. 1) [15]. PC can scav-
enge the radicals, suggesting that C3G would produce another
radical scavenger by its reaction with biological radicals in
vivo. However, it has not been clari¢ed that these oxidation
reactions of C3G occur in vivo, and how C3G is e¡ectively
absorbed, distributed, and metabolized in some tissues.
The purpose of this study was to demonstrate the absorp-
tion, distribution, and metabolism of C3G in rats, and clarify
the mechanism for the antioxidant activity of C3G in vivo.
2. Materials and Methods
2.1. Chemicals
L-Glucuronidase from Ampullaria was purchased from Wako Pure
Chemical Industries, Ltd. (Osaka, Japan). Authentic PC was pur-
chased from Tokyo Kasei Kogyo Co. (Tokyo, Japan). Authentic cy-
anidin (Cy) and peonidin 3-O-L-D-glucoside were obtained from Ex-
trasynthe'se (Genay, France). Sulfatase (type VIII) was purchased
from Sigma Chemical (St. Louis, MO, USA). C3G (purity more
than 96%) was puri¢ed using the commercial food coloring material
(San Red No. 5F, San-Ei Gen F.F.I., Inc., Osaka, Japan) derived
from purple corn (Zea mays L.) using previously described high-per-
formance liquid chromatography (HPLC) [15]. The structure and pu-
rity were con¢rmed by 1H and 13C nuclear magnetic resonance, fast
atom bombardment mass spectrometry (FAB-MS), UV-VIS, and in-
frared spectral data before use.
2.2. Animals and diets
Eighteen 7-week-old male Wistar rats (Japan SLC Inc., Hamamat-
su, Japan; V170 g) were used, and individually housed in stainless-
steel wire-mesh cages at 23 þ 0.3‡C with a 12-h light cycle. The rats
were allowed free access to tap water and a semi-puri¢ed diet. All
animals were fed the control diet containing (g/kg diet) casein, 250;
mineral mixture (AIN93G-MX) [16], 35; vitamin mixture (AIN93-
VX) [16], 10; choline chloride, 2; corn oil, 50; cellulose powder, 40;
and the remainder carbohydrate, 613 (sucrose:starch = 1:2) for 7 days
before the experiment. Rats were maintained in accordance with the
Guidelines for Animal Experimentation of Nagoya University.
2.3. Experimental design and tissue preparation
After 7 days of feeding the control diet, food was withheld for 24 h,
then C3G (0.9 mmol/kg body weight) dissolved in 0.1% citric acid was
orally administered to 15 rats by direct stomach intubation. The rats
were killed 15, 30, 60, 120, or 240 min after the administration by
withdrawing blood by heart puncture using heparinized needles and
syringes under anesthesia with diethyl ether. The plasma was imme-
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diately obtained from the collected blood by centrifugation at 1600Ug
for 15 min at 4‡C. The plasma separation was ¢nished within 30 min.
An aliquot of the plasma was acidi¢ed with one-tenth volume of
phosphoric acid and stored at 380‡C until use. The liver and kidneys
were rapidly excised after being perfused with ice-cold physiological
saline. The stomach and jejunum were washed with ice-cold physio-
logical saline to remove any C3G that adhered to the surface of the
mucosa. The tissue samples were kept at 380‡C until use.
2.4. Determination of C3G and its metabolites in the plasma
The plasma (400 Wl) was mixed with an equal volume of 10 mM
oxalic acid, and the mixtures were subjected to Sep-Pak C18 cartridges
(Waters, USA) [17]. After washing with 10 mM oxalic acid, C3G and
the metabolites were eluted with methanol containing 1% tri£uoro-
acetic acid (TFA). The eluent was carefully evaporated to dryness in
vacuo below 35‡C. The dried extract was dissolved using 100 Wl of
15% acetonitrile in water containing 50 mM sodium phosphate (pH
1.7). An aliquot (20 Wl) of this solution was injected into an HPLC
system. HPLC was carried out on a Develosil ODS-HG-5 column
(Nomura Chemical Co. Ltd., Aichi, Japan, 4.6U250 mm) using
15% acetonitrile in water containing 50 mM sodium phosphate (pH
1.7) for C3G and PC or 20% acetonitrile in water for Cy as a solvent
at a £ow rate of 1.0 ml/min, with a photodiode array detector (MD-
910, Jasco, Tokyo, Japan). The recovery of the method has been
checked (s 88%) using authentic C3G and Cy and PC.
2.5. Determination of C3G and its metabolites in the tissues
Frozen tissue samples (0.5 g) were homogenized in 4 volumes of 0.4
M sodium phosphate bu¡er (pH 3.9) containing 0.1% EDTA using a
Potter-Elvehjem homogenizer. An aliquot (400 Wl) of homogenate was
mixed with 2.0 ml of acetone containing 0.1% TFA and centrifuged at
3000Ug for 5 min at 4‡C. The supernatant was collected and 20 Wl of
TFA was added. The extract was carefully evaporated to dryness in
vacuo below 35‡C. The dried extract was dissolved in 100 Wl of meth-
anol containing 1% TFA. An aliquot (20 Wl) of this solution was
analyzed by HPLC using 18% or 12% acetonitrile in water containing
50 mM sodium phosphate (pH 1.7) as the solvent.
2.6. Identi¢cation of C3G and its metabolites
The identi¢cation of the C3G metabolite in the plasma was per-
formed by UV-VIS spectrometry using the photodiode array detector,
retention time and HPLC-MS. For HPLC-MS, the plasma samples
were applied to the HPLC system, which was connected to a mass
spectrometer (PLATFORM II, Fisons Instruments, UK), on a Devel-
osil ODS-HG-5 column (4.6U250 mm) using 15% acetonitrile con-
taining 0.01% acetic acid as the solvent. The electrospray ionization
(positive) mode was used for the detection. The identi¢cation of C3G
and its metabolites in the plasma, liver and kidneys was performed by
UV-VIS spectrum using the photodiode array detector, retention time
and FAB-MS. For the FAB-MS, C3G and the metabolite were iso-
lated using preparative HPLC with a Develosil ODS-HG-5 column
(4.6U250 mm) monitored by a spectrophotometric detector (530 nm).
The solvent was 18% acetonitrile containing 0.1% TFA. The isolated
samples were applied to FAB-MS using a JEOL JMS-DX-705L
(JEOL, Tokyo, Japan).
2.7. Determination of conjugated C3G and its metabolites in the plasma
and tissues
The plasma or tissue homogenate (400 Wl) was mixed with L-glu-
curonidase (550 U/ml) and sulfatase (25 U/ml) in 1 M acetate bu¡er
(pH 4.5) and incubated at 37‡C for 20 min. The reaction mixture was
centrifuged at 8000Ug for 10 min at 4‡C and the supernatant was
analyzed by HPLC according to the determination procedure of C3G
and its metabolites as already described.
Fig. 1. Chemical structures of C3G, Cy, and PC.
Fig. 2. Typical HPLC chromatogram of rat plasma and kidney ex-
tracts after oral administration of C3G. A: HPLC chromatogram
of rat plasma extracts at 30 min detected at 530 nm using 15% ace-
tonitrile in water containing 50 mM sodium phosphate (pH 1.7) as
the solvent. B: HPLC chromatogram of rat plasma extracts at 60
min detected at 260 nm using 15% acetonitrile in water containing
50 mM sodium phosphate (pH 1.7) as the solvent. C: HPLC chro-
matogram of rat kidney extracts at 30 min detected at 530 nm using
18% acetonitrile in water containing 50 mM sodium phosphate (pH
1.7) as the solvent.
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3. Results and discussion
3.1. C3G and its metabolites in the plasma
The HPLC chromatogram of the plasma obtained from rats
administered C3G showed the peak which was assumed to be
anthocyanins (Fig. 2A). The peak was identi¢ed as C3G by
comparison with the authentic compound based on the reten-
tion time in the HPLC analysis, UV-VIS spectrum, and FAB-
MS. The plasma C3G concentration reached a maximum at
30 min after the administration (0.31 þ 0.03 Wmol/l), and be-
gan to fall from 60 min (Fig. 3A). These results demonstrate
that C3G is absorbed and rapidly enters the circulatory sys-
tem as a glucoside. However, Cy, which is the aglycon of C3G
(Fig. 1), was not detected in the plasma during 4 h after the
administration.
The HPLC chromatogram of the plasma also showed a
peak for a compound assumed to be a metabolite of C3G
(Fig. 2B). The metabolite was identi¢ed as PC (Fig. 1) by
comparison with the authentic compound based on retention
time in the HPLC analysis, UV spectrum and HPLC-MS. The
plasma PC concentration reached a maximum at 60 min
(2.56 þ 0.26 Wmol/l), and it is noteworthy that the concentra-
tion was 8 times that of C3G (Fig. 3A). These results suggest
that plasma PC rather than C3G contributes to the increase in
oxidation resistance of the serum obtained in our previous
study [12].
The enzymatic treatment of the plasma using L-glucuroni-
dase and sulfatase did not cause the appearance of additional
C3G, Cy and PC (data not shown). It seems that these com-
pounds in the plasma are neither conjugated glucuronides nor
sulfates.
3.2. C3G and its metabolites in the tissue
Fig. 3B,C shows the time course of the concentrations of
C3G and its metabolites in the stomach and jejunum after the
administration of C3G. C3G was detected in the stomach
throughout the 4-h period and the concentration reached a
maximum at 15 min (Fig. 3B). On the other hand, Cy and PC
were not detected throughout the 4-h period after the admin-
istration of C3G.
In the jejunum, C3G, Cy and PC were detected throughout
the 4-h period (Fig. 3C). It must be emphasized that Cy was
detected in the jejunum, although it was not detected in the
plasma. Cy would be produced from C3G by L-glucosidase
reactions in the intestines.
PC was also detected in the jejunum throughout the 4-h
period after administration (Fig. 3C). Although the data are
not shown, PC was produced by the degradation of Cy when
Fig. 3. C3G, Cy, and PC concentrations in rat plasma (A), stomach (B) and jejunum (C) after oral administration of C3G. Values are means
þ S.E.M., n = 3.
Fig. 4. C3G and methyl-C3G concentrations in rat liver (A) and kidneys (B) after oral administration of C3G. Values are means þ S.E.M.,
n = 3.
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Cy was incubated with rat plasma for 15 min. It was also
produced from C3G, but more than 16 h was required for
its formation. Therefore, the accumulation of PC in the plas-
ma could be derived from the degradation of Cy, but not
C3G. There are two possibilities that explain the formation
of PC from Cy. One is that PC produced from Cy in the
intestine is absorbed and accumulated in the plasma. The
other is that Cy is absorbed and degraded due to its instability
in the plasma, resulting in the appearance of PC. Although it
remains to be clari¢ed which one is correct, the concentration
of PC in the plasma is much higher than that of C3G or Cy
throughout the 4-h period after the administration of C3G.
Fig. 4 shows the time course of C3G and its metabolite
concentrations in the liver (Fig. 4A) and kidneys (Fig. 4B)
after the administration of C3G. Cy and PC were not detected
in the liver and kidneys throughout the 4-h period after the
C3G administration. C3G was clearly detected in the kidneys
(Fig. 2C), and its concentration reached a maximum at 30 min
(3.20 þ 0.66 nmol/g tissue), but it was not detected in the liver.
This result suggests that C3G in the plasma is e⁄ciently trans-
ferred into the kidney tissue compared to the liver.
The HPLC analysis showed that a peak for the compound
assumed to be an anthocyanin was detected in the liver and
kidneys (Fig. 2C). The peak was identi¢ed as C3G methylated
at the 3P or 4P hydroxyl moiety position (methyl-C3G) by
comparison with the authentic compound as peonidin 3-O-
L-D-glucoside based on the retention time in the HPLC anal-
ysis, UV-VIS spectrum, and FAB-MS. Methyl-C3G was not
detected in the plasma suggesting that it may be formed and
retained in the tissues. The concentration reached a maximum
at 30 min in the liver and kidneys, and the concentration was
2-fold higher in the kidneys (1.32 þ 0.21 nmol/g tissue) (Fig.
4B) than in the liver (0.64 þ 0.01 nmol/g tissue) (Fig. 4A). It is
speculated that C3G is distributed to the liver after absorption
in the intestine, and most C3G in the liver is methylated at its
catechol group by catechol-O-methyltransferase (COMT).
C3G was also e⁄ciently distributed to the kidneys, and prob-
ably methylated by COMT. The concentration of methyl-C3G
in the kidneys was higher than that in the liver. As the con-
centration of C3G in the kidney was also signi¢cantly high,
dietary C3G may selectively improve the antioxidant activity
of the kidneys.
In conclusion, we show here for the ¢rst time how antho-
cyanin is absorbed and metabolized in vivo. After the admin-
istration of C3G, it is hydrolyzed by L-glucosidase and chemi-
cally changed in the intestines. In the plasma, C3G itself and
PC are present, but Cy is not detected. Cy is unstable under
physiological conditions and degraded to PC, even if Cy were
absorbed into the circulatory system. It is known that PC has
a protective potency in carcinogenesis [18]. C3G feeding is
expected to improve the antioxidant capability and chemically
prevent carcinogenesis in vivo. In tissues (liver and kidneys),
methyl-C3G and/or C3G are mainly present, and these com-
pounds may contribute to tissue antioxidant activity. In addi-
tion, glucuronides and sulfates of C3G and its metabolites
were not detected in the plasma and tissues tested. This ob-
servation is completely di¡erent with respect to the other £a-
vonoids. The fact that C3G mainly exists as a free form would
be of bene¢t to its antioxidant activity.
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